SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-20-000582
Filing Date
2020-12-22
Accepted
2020-12-22 17:14:55
Documents
2
Period of Report
2020-12-22
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT FOR 12-22-2020 form_8-k.htm 8-K 10260
2 GRAPHIC angiosoma_logo.jpg GRAPHIC 10351
  Complete submission text file 0001161697-20-000582.txt   25790
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 201408948
SIC: 2834 Pharmaceutical Preparations